A new monoclonal antibody that blocks dimerisation and inhibits c-kit mutation-driven tumour growth | Journal of Cancer Research and Clinical Oncology
Secondary KIT mutations: the GIST of drug resistance and sensitivity | British Journal of Cancer
Exposure of neuroblastoma cell lines to imatinib results in the upregulation of the CDK inhibitor p27KIP1 as a consequence of c-Abl inhibition - ScienceDirect
Using Imatinib for Adjuvant Treatment after Resection of Kit-positive GIST - The ASCO Post
Traces of cKIT model and imatinib binding. A, model of the inactive... | Download Scientific Diagram
![PDF] c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1a2caa75b0240b9cad38286da89c68152befd2d7/11-Figure9-1.png "PDF] c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. | Semantic Scholar")
PDF] c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty. | Semantic Scholar
EPOS™
Imatinib - Wikipedia
KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients | PNAS
For How Long Should Adjuvant Therapy for Gastrointestinal Stromal Tumors (GIST) Be Administered?
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors - ScienceDirect
Diapositiva 1
A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors - Kim - 2022 - Molecular Oncology - Wiley Online Library
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review | Biomolecules and Biomedicine
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review | Biomolecules and Biomedicine
The KIT receptor tyrosine kinase. (A) C-KIT mutations occur in 80 –90%... | Download Scientific Diagram
Hypothetical schema for the effects of imatinib on osteoclasts and... | Download Scientific Diagram
c-KIT and PDGFRA mutation detection for GIST – آزمایشگاه پرتولب
Imatinib Mesylate — A New Oral Targeted Therapy | NEJM
JCI - An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
![PDF] The SCF/c-KIT system and imatinib actions in prostate cancer: a cross-talk with RGN? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/52568705464442ace5fec86bca4a1528e3281c4b/70-FigureV-1.png "PDF] The SCF/c-KIT system and imatinib actions in prostate cancer: a cross-talk with RGN? | Semantic Scholar")
PDF] The SCF/c-KIT system and imatinib actions in prostate cancer: a cross-talk with RGN? | Semantic Scholar
Imatinib‑induced apoptosis of gastric cancer cells is mediated by endoplasmic reticulum stress
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours | British Journal of Cancer
The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor - ScienceDirect
Journal of Biomedical and Pharmaceutical Research
Cancer drug gets a makeover | News | Chemistry World
